Medical management of sporadic and hereditary gastrinoma: An update approach and its limits
作者： M. Mignon , V. Ratziu
DOI: 10.1007/BF02601970
关键词:
摘要: Medical management of patients with Zollinger-Ellison syndrome (ZES) has considerably evolved since initial reports in 1955 and especially over the last decade. Control gastric acid hypersecretion by effective antisecretory drugs, accurate localization staging tumoral process modern medical imaging techniques as well progress surgical skill undoubtedly account for higher rates gastrinoma definitive or long-lasting cure. Elective surgery removal may indeed be safely undertaken selected patients. Current diagnostic treatment strategies have been discussed here, reference to literature a large personal series followed at Bichat-Claude Bernard Hospital 30 years. The specific case associated multiple endocrine neoplasia type I is also discussed.
springer.com
sci-hub.se 参考文章(44)
Paul N. Maton, The Use of the Long-Acting Somatostatin Analogue, Octreotide Acetate, in Patients with Islet Cell Tumors Gastroenterology Clinics of North America. ,vol. 18, pp. 897- 922 ,(1989) , 10.1016/S0889-8553(21)00447-7
Paul N. Maton, John L. Doppman, Jeffrey A. Norton, Jerry D. Gardner, Robert T. Jensen, Mary Jo Cornelius, Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery. ,vol. 102, pp. 958- 966 ,(1987) , 10.5555/URI:PII:0039606087903230
P.N. Maton, R. Vinayek, H. Frucht, K.A. McArthur, L.S. Miller, Z.A. Saeed, J.D. Gardner, R.T. Jensen, Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology. ,vol. 97, pp. 827- 836 ,(1989) , 10.1016/0016-5085(89)91485-6
J.D. Gardner, R.T. Jensen, P.N. Maton, L.S. Miller, R. Vinayek, H. Frucht, Reflux esophagitis in patients with Zollinger-Ellison syndrome Gastroenterology. ,vol. 98, pp. 341- 346 ,(1990) , 10.1016/0016-5085(90)90823-J
J.M. Howard, A.N. Chremos, M.J. Collen, K.E. Mcarthur, J.A. Cherner, P.N. Maton, C.A. Ciarleglio, M.J. Cornelius, J.D. Gardner, R.T. Jensen, Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology. ,vol. 88, pp. 1026- 1033 ,(1985) , 10.1016/S0016-5085(85)80024-X
Jean-Claude Reubi, Wout A. Breeman, Jan W. Koper, Steven W. Lamberts, Willem H. Bakker, Marion de Jong, Eric P. Krenning, Theo J. Visser, Johannes S. Laméris, Peter P. M. Kooij, In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. The Journal of Nuclear Medicine. ,vol. 32, pp. 1184- 1189 ,(1991)
JEFFREY A. NORTON, JOHN L. DOPPMAN, MARTIN J. COLLEN, JOHN W. HARMON, PAUL N. MATON, JERRY D. GARDNER, ROBERT T. JENSEN, Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Annals of Surgery. ,vol. 204, pp. 468- 479 ,(1986) , 10.1097/00000658-198610000-00015
K. A. LLOYD-DAVIES, K. RUTGERSSON, L. SÖLVELL, Omeprazole in the treatment of Zollinger—Ellison syndrome: a 4‐year international study Alimentary Pharmacology & Therapeutics. ,vol. 2, pp. 13- 32 ,(2007) , 10.1111/J.1365-2036.1988.TB00667.X
TOSHIO AOYAGI, Gastric Secretion With Ulcerogenic Islet Cell Tumor: Importance of Basal Acid Output JAMA Internal Medicine. ,vol. 117, pp. 667- 672 ,(1966) , 10.1001/ARCHINTE.1966.03870110059012
Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C, Toxicological studies on omeprazole. Scandinavian Journal of Gastroenterology. ,vol. 108, pp. 53- 69 ,(1985) , 10.3109/00365528509095819